The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611
Spread of SARS-CoV-2 in the Icelandic population
Gudbjartsson, D. F., Helgason, A., Jonsson, H., Magnusson, O. T., Melsted, P., Norddahl, G. L., Saemundsdottir, J., Sigurdsson, A., Sulem, P., Agustsdottir, A. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2006100 · Cited by 1,248
Research works printed but not linked: 16
- 10.1016/j.ijid.2020.03.020 · DOI · Paper page
- 10.1001/jama.2020.2565 · DOI · Paper page
- 10.1056/NEJMc2001737 · DOI · Paper page
- 10.15585/mmwr.mm6913e1 · DOI · Paper page
- 10.15585/mmwr.mm6912e3 · DOI · Paper page
- 10.1056/NEJMc2009316 · DOI · Paper page
- 10.1093/jtm/taaa054 · DOI
- 10.1056/NEJMoa2008457 · DOI · Paper page
- 10.1136/thoraxjnl-2020-215091 · DOI · Paper page
- Inui S, 2020, Radiol Cardiothorac Imaging, 2, 10
- 10.2807/1560-7917.ES.2020.25.10.2000180 · DOI · Paper page
- 10.1001/jama.2020.6887 · DOI · Paper page
- 10.1001/jamanetworkopen.2020.10182 · DOI · Paper page
- 10.1093/cid/ciy073 · DOI
- 10.1177/1460458219897152 · DOI
- 10.1016/S2589-7500(19)30222-5 · DOI · Paper page
Cited by
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
Weinreich, D. M., Sivapalasingam, S., Norton, T., Ali, S., Gao, H., Bhore, R., Musser, B. J., Soo, Y., Rofail, D., Im, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035002 · Cited by 1,642
Airborne transmission of respiratory viruses
Wang, C. C., Prather, K. A., Sznitman, J., Jimenez, J. L., Lakdawala, S. S., Tufekci, Z., & Marr, L. C. (2021) · Science · doi:10.1126/science.abd9149 · Cited by 1,543
Townsend, L., Dyer, A. H., Jones, K., Dunne, J., Mooney, A., Gaffney, F., O'Connor, L., Leavy, D., O'Brien, K., Dowds, J., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240784 · Cited by 911
Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report
Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., et al. (2020) · doi:10.1101/2020.06.22.20137273 · Cited by 11,475
Levin, A. T., Hanage, W. P., Owusu-Boaitey, N., Cochran, K. B., Walsh, S. P., & Meyerowitz-Katz, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00698-1 · Cited by 844
Miller, S. L., Nazaroff, W. W., Jimenez, J. L., Boerstra, A., Buonanno, G., Dancer, S. J., Kurnitski, J., Marr, L. C., Morawska, L., & Noakes, C. (2021) · Indoor Air · doi:10.1111/ina.12751 · Cited by 734
Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study
Kretzschmar, M. E., Rozhnova, G., Bootsma, M. C. J., van Boven, M., van de Wijgert, J. H. H. M., & Bonten, M. J. M. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30157-2 · Cited by 697
(2020) · doi:10.3138/jammi-2020-0030 · Cited by 664
Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30773-8 · Cited by 633
Galani, I.-E., Rovina, N., Lampropoulou, V., Triantafyllia, V., Manioudaki, M., Pavlos, E., Koukaki, E., Fragkou, P. C., Panou, V., Rapti, V., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00840-x · Cited by 503
Röltgen, K., Powell, A. E., Wirz, O. F., Stevens, B. A., Hogan, C. A., Najeeb, J., Hunter, M., Wang, H., Sahoo, M. K., Huang, C., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abe0240 · Cited by 452
Wearable sensor data and self-reported symptoms for COVID-19 detection
Quer, G., Radin, J. M., Gadaleta, M., Baca-Motes, K., Ariniello, L., Ramos, E., Kheterpal, V., Topol, E. J., & Steinhubl, S. R. (2021) · Nature Medicine · doi:10.1038/s41591-020-1123-x · Cited by 447
Self-citationImmunological characteristics govern the transition of COVID-19 to endemicity
Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416
Bundgaard, H., Bundgaard, J. S., Raaschou-Pedersen, D. E. T., von Buchwald, C., Todsen, T., Norsk, J. B., Pries-Heje, M. M., Vissing, C. R., Nielsen, P. B., Winsløw, U. C., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6817 · Cited by 388
Causal impact of masks, policies, behavior on early COVID-19 pandemic in the U.S
Chernozhukov, V., Kasahara, H., & Schrimpf, P. (2021) · Journal of Econometrics · doi:10.1016/j.jeconom.2020.09.003 · Cited by 403
COVID-19 vaccines: The status and perspectives in delivery points of view
Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375
Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection
Butowt, R., & von Bartheld, C. S. (2021) · The Neuroscientist · doi:10.1177/1073858420956905 · Cited by 345
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Uyoga, S., Adetifa, I. M. O., Karanja, H. K., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., et al. (2021) · Science · doi:10.1126/science.abe1916 · Cited by 328
Recent endemic coronavirus infection is associated with less severe COVID-19
Sagar, M., Reifler, K., Rossi, M., Miller, N. S., Sinha, P., White, L. F., & Mizgerd, J. P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143380 · Cited by 324
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
Kemp, S. A., Meng, B., Ferriera, I. A., Datir, R., Harvey, W. T., Papa, G., Lytras, S., Collier, D. A., Mohamed, A., Gallo, G., et al. (2020) · doi:10.1101/2020.12.14.422555 · Cited by 252
Cheemarla, N. R., Watkins, T. A., Mihaylova, V. T., Wang, B., Zhao, D., Wang, G., Landry, M. L., & Foxman, E. F. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20210583 · Cited by 213
Burden and characteristics of COVID-19 in the United States during 2020
Pei, S., Yamana, T. K., Kandula, S., Galanti, M., & Shaman, J. (2021) · Nature · doi:10.1038/s41586-021-03914-4 · Cited by 190
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Vanshylla, K., Di Cristanziano, V., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.04.015 · Cited by 153
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Butt, A. A., Coyle, P., Jeremijenko, A., Kaleeckal, A. H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-85428-7 · Cited by 148
Adenaiye, O. O., Lai, J., Bueno de Mesquita, P. J., Hong, F., Youssefi, S., German, J., Tai, S. H. S., Albert, B., Schanz, M., Weston, S., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciab797 · Cited by 125
Digital proximity tracing on empirical contact networks for pandemic control
(2021) · doi:10.1038/s41467-021-21809-w · Cited by 123
The timing of COVID-19 transmission
Ferretti, L., Ledda, A., Wymant, C., Zhao, L., Ledda, V., Abeler-Dörner, L., Kendall, M., Nurtay, A., Cheng, H.-Y., Ng, T.-C., et al. (2020) · doi:10.1101/2020.09.04.20188516 · Cited by 112
Coppock, H., Gaskell, A., Tzirakis, P., Baird, A., Jones, L., & Schuller, B. (2021) · BMJ Innovations · doi:10.1136/bmjinnov-2021-000668 · Cited by 108
Jeremijenko, A., Chemaitelly, H., Ayoub, H. H., Alishaq, M., Abou-Samra, A.-B., Al Ajmi, J. A. A. A., Al Ansari, N. A. A., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., et al. (2021) · Emerging Infectious Diseases · doi:10.3201/eid2705.204365 · Cited by 97
Jensen, M. T., Treskes, R. W., Caiani, E. G., Casado-Arroyo, R., Cowie, M. R., Dilaveris, P., Duncker, D., Di Rienzo, M., Frederix, I., De Groot, N., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab011 · Cited by 93
Discrete SARS-CoV-2 antibody titers track with functional humoral stability
Bartsch, Y. C., Fischinger, S., Siddiqui, S. M., Chen, Z., Yu, J., Gebre, M., Atyeo, C., Gorman, M. J., Zhu, A. L., Kang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21336-8 · Cited by 82
Masks and Face Coverings for the Lay Public: A Narrative Update
Czypionka, T., Greenhalgh, T., Bassler, D., & Bryant, M. B. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6625 · Cited by 82
Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Coyle, P., Tang, P., Yassine, H. M., Al-Khatib, H. A., Smatti, M. K., Hasan, M. R., Al-Kanaani, Z., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00287-7 · Cited by 76
Lin, Y.-C., Malott, R. J., Ward, L., Kiplagat, L., Pabbaraju, K., Gill, K., Berenger, B. M., Hu, J., Fonseca, K., Noyce, R. S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-09218-5 · Cited by 74
Jiang, C., Wang, Y., Hu, M., Wen, L., Wen, C., Wang, Y., Zhu, W., Tai, S., Jiang, Z., Xiao, K., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1182 · Cited by 72
Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2
Petter, E., Mor, O., Zuckerman, N., Oz-Levi, D., Younger, A., Aran, D., & Erlich, Y. (2021) · doi:10.1101/2021.02.08.21251329 · Cited by 71
The neurobiology of SARS-CoV-2 infection
Meinhardt, J., Streit, S., Dittmayer, C., Manitius, R. V., Radbruch, H., & Heppner, F. L. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00769-8 · Cited by 64
COVID-19 Outbreak at an Overnight Summer School Retreat ― Wisconsin, July–August 2020
Pray, I. W., Gibbons-Burgener, S. N., Rosenberg, A. Z., Cole, D., Borenstein, S., Bateman, A., Pevzner, E., & Westergaard, R. P. (2020) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6943a4 · Cited by 53
Golubchik, T., Lythgoe, K. A., Hall, M., Ferretti, L., Fryer, H. R., MacIntyre-Cockett, G., de Cesare, M., Trebes, A., Piazza, P., Buck, D., et al. (2021) · doi:10.1101/2021.01.12.20249080 · Cited by 45
Pathela, P., Crawley, A., Weiss, D., Maldin, B., Cornell, J., Purdin, J., Schumacher, P. K., Marovich, S., Li, J., Daskalakis, D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab200 · Cited by 52
Quattrocchi, A., Mamais, I., Tsioutis, C., Christaki, E., Constantinou, C., Koliou, M., Pana, Z.-D., Silvestros, V., Theophanous, F., Haralambous, C., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113598 · Cited by 28
Kyaw, M. H., Spinardi, J. R., Jagun, O., Franco Villalobos, C., Kapetanakis, V., Sharf-Williams, R., & Yarnoff, B. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-081019 · Cited by 6
Metadata
- Authors
- Oran, D. P., & Topol, E. J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2020-09-01
- Volume
- 173
- Issue
- 5
- Pages
- 362-367
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3165838540
- Cited by
- 2,279
- References
- 2
- FWCI
- 62.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.